A recent article demonstrated promising results where Glypican-3 (GPC3), a cell surface proteoglycan frequently overexpressed in certain types of cancer expression, significantly differentiated MPD and IDC from other breast cancer histological subtypes. This evidence concerns the gene GPC3 and cancer.